The University of North Florida Materials Science and Engineering Research Facility (MSERF) has partnered with TESCAN, a leading manufacturer of electron and light microscopes, in the installation of one of its new Q-Phase microscopes, a unique instrument for quantitative phase imaging based on holographic microscopy.
The Q-Phase microscope is a one-of-a-kind holographic microscope capable of imaging live cells for up to five days. Traditional light microscopy of cells requires staining and chemical treatments that capture the state of the cell in time but kills the cell in the process. This new technology allows cells to be imaged while living over the course of days.
“The partnership with TESCAN affords the University the ability to gather cutting-edge data from the latest high-tech equipment” said Dr. Paul Eason, UNF-MSERF director and associate professor of mechanical engineering in the College of Computing, Engineering and Construction.
The agreement between the University and TESCAN provides UNF the opportunity to house brand new and unique microscopes for the purpose of instrument validation and demonstration for potential users. The Q-Phase microscope, housed at MSERF in the newly renovated Skinner-Jones Hall, is on the UNF campus for a 90-day trial installation.
Researchers both at UNF and the Mayo Clinic are taking advantage of the trial installation and utilizing the high-powered device in their respective studies of treating various types of cancer.
Image Credit: AZO Nano
News This Week
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Leave A Comment